AstraZeneca sues US over Medicare drug price negotiation plans
AstraZeneca has sued the U.S. government to block a program that allows Medicare to negotiate lower drug prices, claiming that it would hinder the development of new medicines.
AstraZeneca has sued the U.S. government to block a program that allows Medicare to negotiate lower drug prices, claiming that it would hinder the development of new medicines.